Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)
| Market Cap | 3.41B+91.2% |
| Revenue (ttm) | 0+100.0% |
| Net Income | -152.09M+18.9% |
| EPS | -1.41+43.6% |
| Shares Out | 125.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Mar 28, 2018 |
| Volume | 1,158,753 |
| Open | 28.46 |
| Previous Close | 28.57 |
| Day's Range | 27.06 - 28.46 |
| 52-Week Range | 10.83 - 41.14 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 52.20(+91.91%) |
| Earnings Date | Nov 5, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About AMLX
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$AMLX stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in AMLX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by AMLX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
AMLX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New AMLX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to AMLX from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in AMLX
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $110.64M |
| IWMiShares Russell 2000 ETF | $74.57M |
| VXFVanguard Extended Market ETF | $33.63M |
| IWOiShares Russell 2000 Growth ETF | $27.63M |
| IBBiShares Biotechnology ETF | $23.16M |
| VTWOVanguard Russell 2000 ETF | $17.53M |
Estimated from each fund’s disclosed top holdings × AUM
AMLX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from AMLX’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score